BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 30398107)

  • 1. A Network-Based Cancer Drug Discovery: From Integrated Multi-Omics Approaches to Precision Medicine.
    Turanli B; Karagoz K; Gulfidan G; Sinha R; Mardinoglu A; Arga KY
    Curr Pharm Des; 2018; 24(32):3778-3790. PubMed ID: 30398107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Networks and games for precision medicine.
    Biane C; Delaplace F; Klaudel H
    Biosystems; 2016 Dec; 150():52-60. PubMed ID: 27543134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MOBCdb: a comprehensive database integrating multi-omics data on breast cancer for precision medicine.
    Xie B; Yuan Z; Yang Y; Sun Z; Zhou S; Fang X
    Breast Cancer Res Treat; 2018 Jun; 169(3):625-632. PubMed ID: 29429018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
    Tebani A; Afonso C; Marret S; Bekri S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery.
    Zhou Y; Fang J; Bekris LM; Kim YH; Pieper AA; Leverenz JB; Cummings J; Cheng F
    Alzheimers Res Ther; 2021 Jan; 13(1):24. PubMed ID: 33441136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing drug-response prediction using multi-modal and -omics machine learning integration (MOMLIN): a case study on breast cancer clinical data.
    Rashid MM; Selvarajoo K
    Brief Bioinform; 2024 May; 25(4):. PubMed ID: 38904542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics Approaches for Anti-cancer Drug Discovery.
    Li K; Du Y; Li L; Wei DQ
    Curr Drug Targets; 2020; 21(1):3-17. PubMed ID: 31549592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
    Verkhivker GM
    Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "
    Gemmati D; Varani K; Bramanti B; Piva R; Bonaccorsi G; Trentini A; Manfrinato MC; Tisato V; Carè A; Bellini T
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
    Wang Y; Yang Y; Chen S; Wang J
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep learning assisted multi-omics integration for survival and drug-response prediction in breast cancer.
    Malik V; Kalakoti Y; Sundar D
    BMC Genomics; 2021 Mar; 22(1):214. PubMed ID: 33761889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical multi-omics strategies for the effective cancer management.
    Yoo BC; Kim KH; Woo SM; Myung JK
    J Proteomics; 2018 Sep; 188():97-106. PubMed ID: 28821459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of pharmacometrics and quantitative systems pharmacology to cancer therapy: The example of luminal a breast cancer.
    Fleisher B; Brown AN; Ait-Oudhia S
    Pharmacol Res; 2017 Oct; 124():20-33. PubMed ID: 28735000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidence.
    Hampel H; Nisticò R; Seyfried NT; Levey AI; Modeste E; Lemercier P; Baldacci F; Toschi N; Garaci F; Perry G; Emanuele E; Valenzuela PL; Lucia A; Urbani A; Sancesario GM; Mapstone M; Corbo M; Vergallo A; Lista S;
    Ageing Res Rev; 2021 Aug; 69():101346. PubMed ID: 33915266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology.
    Lim H; He D; Qiu Y; Krawczuk P; Sun X; Xie L
    PLoS Comput Biol; 2019 Jun; 15(6):e1006619. PubMed ID: 31206508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omics and Exercise: Global Approaches for Mapping Exercise Biological Networks.
    Hoffman NJ
    Cold Spring Harb Perspect Med; 2017 Oct; 7(10):. PubMed ID: 28348175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying Risk Pathway Crosstalk Mediated by miRNA to Screen Precision drugs for Breast Cancer Patients.
    Xu Y; Lin S; Zhao H; Wang J; Zhang C; Dong Q; Hu C; Desi S; Wang L; Xu Y
    Genes (Basel); 2019 Aug; 10(9):. PubMed ID: 31466383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems Biology Approaches and Precision Oral Health: A Circadian Clock Perspective.
    Adeola HA; Papagerakis S; Papagerakis P
    Front Physiol; 2019; 10():399. PubMed ID: 31040792
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.